Viracta Therapeutics, Inc.
VIRX · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$51,058 | -$49,197 | -$114,762 | -$19,017 |
| Dep. & Amort. | $492 | $210 | $178 | $32 |
| Deferred Tax | $0 | $0 | $290 | $0 |
| Stock-Based Comp. | $7,649 | $13,548 | $5,542 | $348 |
| Change in WC | $5,079 | $608 | $1,680 | $2,571 |
| Other Non-Cash | -$2,054 | -$626 | $88,221 | $12 |
| Operating Cash Flow | -$39,892 | -$35,457 | -$18,851 | -$16,054 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$138 | -$45 | -$4,252 | -$55 |
| Net Acquisitions | $0 | $0 | $17,143 | $0 |
| Inv. Purchases | -$67,136 | -$70,620 | $0 | -$747 |
| Inv. Sales/Matur. | $82,272 | $16,799 | $0 | $17,154 |
| Other Inv. Act. | $0 | $0 | $13,143 | -$16,407 |
| Investing Cash Flow | $14,998 | -$53,866 | $12,891 | -$55 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $19,986 | -$234 | $5,260 |
| Stock Issued | $299 | $2,331 | $62,320 | $851 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $139 | $225 | $339 | $77,738 |
| Financing Cash Flow | $438 | $22,542 | $62,425 | $44,980 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$24,456 | -$66,781 | $56,465 | $28,871 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $36,773 | $103,554 | $47,089 | $18,218 |
| End Cash | $12,317 | $36,773 | $103,554 | $47,089 |
| Free Cash Flow | -$40,030 | -$35,502 | -$23,103 | -$16,109 |